Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ClōSYS is an over-the-counter oral health rinse primarily used as a mouthwash to eliminate oral malodor (bad breath), cleanse the oral cavity, and aid in the prevention of dental cavities. Its key active ingredient is stabilized chlorine dioxide (marketed as Cloralstan), which is a buffered sodium chlorite solution. When exposed to amino acids in saliva or acidic conditions produced by bacteria in biofilms, the stabilized chlorine dioxide is activated and acts as an antimicrobial agent—killing dental plaque-causing bacteria and neutralizing volatile sulfur compounds that contribute to bad breath and soft tissue damage. Some formulations also contain sodium fluoride for anticavity protection. The product is alcohol-free, pH-balanced, non-irritating even for sensitive mouths, and available with or without added flavoring agents such as peppermint oil[1][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on closys.